Hochschulschrift
Use of tumor vasculature for successful treatment of carcinomas by oncolytic vaccinia virus
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Dimensions
-
30 cm
- Extent
-
VII, 117 Blätter
- Language
-
Englisch
- Notes
-
Illustrationen, Diagramme
Julius-Maximilians-Universität Würzburg, Dissertation, 2015
- Classification
-
Medizin, Gesundheit
Biowissenschaften, Biologie
- Keyword
-
Vaccinia-Virus
Onkolyse
Angiogenese
- Table of contents
- Rights
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Last update
-
11.03.2025, 12:23 PM CET
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Object type
- Hochschulschrift
Associated
Time of origin
- 2015
Other Objects (12)
Use of Tumor Vasculature for Successful Treatment of Carcinomas by Oncolytic Vaccinia Virus
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Cellular Factors Contributing to Host Cell Permissiveness in Support of Oncolytic Vaccinia Virus Replication
Comparative analysis of vaccinia virus encoded markers reflecting actual viral titres in oncolytic virotherapy
Use of Tumor Vasculature for Successful Treatment of Carcinomas by Oncolytic Vaccinia Virus
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Cellular Factors Contributing to Host Cell Permissiveness in Support of Oncolytic Vaccinia Virus Replication
Comparative analysis of vaccinia virus encoded markers reflecting actual viral titres in oncolytic virotherapy
Use of Tumor Vasculature for Successful Treatment of Carcinomas by Oncolytic Vaccinia Virus
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Influence of oncolytic vaccinia viruses on metastases of human and murine tumors
Characterization of Murine GL261 Glioma Models for Oncolytic Vaccinia Virus Therapy
Characterization of murine GL261 glioma models for oncolytic vaccinia virus therapy
Oncolytic virotherapy and modulation of tumor microenvironment with vaccinia virus strains
Preclinical Evaluation of Oncolytic Vaccinia Virus for Therapy of Canine Soft Tissue Sarcoma
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Effects of stem cell transcription factor-expressing vaccinia viruses in oncolytic virotherapy
Comparative Analysis of Vaccinia Virus-Encoded Markers Reflecting Actual Viral Titres in Oncolytic Virotherapy
Cellular Factors Contributing to Host Cell Permissiveness in Support of Oncolytic Vaccinia Virus Replication